Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea.
Kim ES, Kim HB, Kim G, Kim KH, Park KH, Lee S, Choi YH, Yi J, Kim CJ, Song KH, Choe PG, Kim NJ, Lee YS, Oh MD; Korea INfectious Diseases (KIND) study group. Kim ES, et al. PLoS One. 2014 Dec 8;9(12):e114127. doi: 10.1371/journal.pone.0114127. eCollection 2014. PLoS One. 2014. PMID: 25485895 Free PMC article.
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting Readiness.
Chan K, Palis BE, Cotler JH, Janczewski LM, Zhu X, Boffa DJ, Park KU, Boughey JC, Plichta JK, In H, Nogueira LM, Yabroff RK, Hawhee VM, Merriman KW, Habermann EB, Williams VL, Mason K, Mullett TW, Weigel RJ, Nelson H. Chan K, et al. Among authors: park ku. Ann Surg Oncol. 2024 Dec 31. doi: 10.1245/s10434-024-16801-9. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39739153
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18.
Choi DH, Kim M, Kim YS, Park KU, Cho JH, Kim H, Lee KH, Ahn H, Kim IH, Lee KH, Lee GW, Yi SY, Ahn BC, Lee MY, Jung HA, Park S, Sun JM, Ahn JS, Lee SH, Ahn MJ. Choi DH, et al. Among authors: park ku. JTO Clin Res Rep. 2024 Oct 16;5(12):100734. doi: 10.1016/j.jtocrr.2024.100734. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39619275 Free PMC article.
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN Jr, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey JC. Singh P, et al. Among authors: park ku. Ann Surg Oncol. 2025 Feb;32(2):899-911. doi: 10.1245/s10434-024-16484-2. Epub 2024 Nov 13. Ann Surg Oncol. 2025. PMID: 39538100 Review.
428 results